About Mednax Inc
Ticker
info
MD
Trading on
info
NYSE
ISIN
info
US58502B1061
Industry
info
Medical Care Facilities
Sector
info
Healthcare
CEO
info
Mark S. Ordan
Headquarters
info
1301 Concord Terrace, Sunrise, FL, United States, 33323
Employees
info
4,120
Website
info
pediatrix.com
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal medicine nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and other newborn and pediatric care, as well as newborn hearing screening, and support services in hospitals, pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Metrics
BasicAdvanced
Market cap
info
$1.81B
P/E ratio
info
11.04
EPS
info
$1.91
Dividend Yield
info
0.00%
Beta
info
1.26
Forward P/E ratio
info
9.29
EBIDTA
info
$237M
Ex dividend date
info
-
Price & volume
Market cap
info
$1.81B
Average daily volume
info
0.9M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
11.04
Forward P/E
info
9.29
PEG ratio
info
0.88
Trailing P/E
info
11.04
Price to sales
info
0.93
Price to book
info
1.78
Earnings
EPS
info
$1.91
EPS estimate (current quarter)
info
$0.47
EPS estimate (next quarter)
info
$0.46
EBITDA
info
$237M
Revenues (TTM)
info
$1.94B
Revenues per share (TTM)
info
$23.07
Technicals
Beta
info
1.26
52-week High
info
$22.38
52-week Low
info
$11.84
50-day moving average
info
$16.83
200-day moving average
info
$14.67
Short ratio
info
3.7
Short %
info
4.41%
Management effectiveness
ROE (TTM)
info
14.27%
ROA (TTM)
info
6.50%
Profit margin
info
5.66%
Gross profit margin
info
$473M
Operating margin
info
13.59%
Growth
Quarterly earnings growth (YoY)
info
392.90%
Quarterly revenue growth (YoY)
info
-7.00%
Share stats
Outstanding Shares
info
85.9M
Float
info
84.2M
Insiders %
info
2.12%
Institutions %
info
97.13%
Analyst Insights & forecasts
info

38% Buy

62% Hold

0% Sell

Based on information from 8 analysts.

Average price target

info
$18.75
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.51
$0.36
39.88%
Q4 • 24Beat
$0.24
$0.26
-8.28%
Q1 • 25Missed
$0.53
$0.42
26.19%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$469M
$39.3M
8.37%
Q2 • 25
$493M
$71.7M
14.55%
Q3 • 25
5.13%
82.65%
73.74%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$2.1B
$1.27B
60.34%
Q2 • 25
$2.2B
$1.31B
59.50%
Q3 • 25
4.63%
3.18%
-1.38%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$137M
$-7.2M
$-4.3M
$133M
Q2 • 25
$140M
-
$-28.6M
$135M
Q3 • 25
2.38%
-
570.63%
1.84%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Mednax Inc share?
Collapse

Mednax Inc shares are currently traded for undefined per share.

How many shares does Mednax Inc have?
Collapse

Mednax Inc currently has 85.9M shares.

Does Mednax Inc pay dividends?
Collapse

No, Mednax Inc doesn't pay dividends.

What is Mednax Inc 52 week high?
Collapse

Mednax Inc 52 week high is $22.38.

What is Mednax Inc 52 week low?
Collapse

Mednax Inc 52 week low is $11.84.

What is the 200-day moving average of Mednax Inc?
Collapse

Mednax Inc 200-day moving average is $14.67.

Who is Mednax Inc CEO?
Collapse

The CEO of Mednax Inc is Mark S. Ordan.

How many employees Mednax Inc has?
Collapse

Mednax Inc has 4,120 employees.

What is the market cap of Mednax Inc?
Collapse

The market cap of Mednax Inc is $1.81B.

What is the P/E of Mednax Inc?
Collapse

The current P/E of Mednax Inc is 11.04.

What is the EPS of Mednax Inc?
Collapse

The EPS of Mednax Inc is $1.91.

What is the PEG Ratio of Mednax Inc?
Collapse

The PEG Ratio of Mednax Inc is 0.88.

What do analysts say about Mednax Inc?
Collapse

According to the analysts Mednax Inc is considered a hold.